Oxford-AstraZeneca

UK medicines regulator has approved the coronavirus vaccine developed by Oxford University and drugmaker AstraZeneca, for emergency supply. 

Clinical trial results showed that the jab is up to 90% effective in preventing COVID-19. 

This is the second vaccine to be approved in the UK after the Pfizer-BioNTech vaccine was given the go-ahead back in December. 

Britain has bought 100 million doses of the vaccine, and according to British Health Secretary Matt Hancock, the new jab will be rolled out from 4th January. 

Speaking to Sky News, Hancock said that the news “brings forward the day when we can get our lives back to normal.”

“We can say now with confidence that we can get out of this by spring.”

In a statement, AstraZeneca CEO Pascal Soriot said: “Today is an important day for millions of people in the UK who will get access to this new vaccine. It has been shown to be effective, well-tolerated, simple to administer and is supplied by AstraZeneca at no profit.”

Featured Image: AstraZeneca.com

Related

Google

Google parent company Alphabet set to buy cybersecurity startup Wiz, its biggest acquisition yet

July 16, 2024
by Anthea Cachia

Acquisiton figures are double the valuation of the company

Blue checkmarks deceive users, European Commission tells Elon Musk’s X

July 12, 2024
by Robert Fenech

The firm faces huge fines if the preliminary findings are upheld

‘Change begins now’: Labour sweeps to power in crushing UK election victory

July 5, 2024
by Robert Fenech

The party secured a large majority in the UK's 650-seat parliament